Y拦截香港有限公司增加了对医疗设备供应商STERIS plc的股份63.4%。 Y Intercept Hong Kong Ltd increased its stake in medical equipment provider STERIS plc by 63.4%.

包括Y拦截香港有限公司在内的机构投资者已经调整了对医疗设备供应商STERIS plc的股份,Y拦截公司将持有量增加了63.4%。 Institutional investors, including Y Intercept Hong Kong Ltd, have adjusted their stakes in medical equipment provider STERIS plc, with Y Intercept increasing its holdings by 63.4%. 尽管略微缺少收入预期,但STERIS的评级是“移动买家”,价格目标为258.75美元。 Despite slightly missing earnings expectations, STERIS has a "Moderate Buy" rating and a $258.75 price target. 该公司价值219.9亿美元,通过四个部分提供预防感染产品:保健、应用绝育技术、生命科学和牙科。 The company, valued at $21.99 billion, provides infection prevention products through four segments: Healthcare, Applied Sterilization Technologies, Life Sciences, and Dental.